Silo Pharma, Inc.

Contributing Author

Recent Articles by Silo Pharma, Inc.

Jun-05	Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset SILO GlobeNewswire
May-21	Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15 SILO GlobeNewswire
May-16	Silo Pharma Announces Closing of $2 Million Public Offering SILO GlobeNewswire
May-15	Silo Pharma Announces Pricing of $2 Million Public Offering SILO GlobeNewswire
May-14	Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15 SILO GlobeNewswire
May-14	Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories SILO GlobeNewswire